Verdence Capital Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Verdence Capital Advisors's ZBH Position: Q4 2025 in Review
Verdence Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,163 shares — an estimated $223K sold.
Verdence Capital Advisors first reported a position in ZBH in Q2 2021 and held it in 17 quarters. The position peaked at $397K in Q2 2021. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Verdence Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Verdence Capital Advisors sold 2,163 Zimmer Biomet shares in Q4 2025, an estimated $223K.
- Verdence Capital Advisors first reported a position in Zimmer Biomet in Q2 2021 and held it in 17 quarters.
- Verdence Capital Advisors's Zimmer Biomet position peaked at $397K in Q2 2021.
- 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Verdence Capital Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.